Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
OtherResearch Paper

Analysis of virus clearance for biotechnology manufacturing processes from early to late phase development

Opeyemi O. Ajayi, Jackie L. Cullinan, Innara Basria, Madaisabel Fuentes-Arias, Ashley Osuna-Najarro, Sarah Johnson, Talia Faison and Scott Lute
PDA Journal of Pharmaceutical Science and Technology April 2025, pdajpst.2025-000001; DOI: https://doi.org/10.5731/pdajpst.2025-000001.1
Opeyemi O. Ajayi
1Center for Drug Evaluation and Research (CDER), Office of Pharmaceutical Quality (OPQ), Office of Product Quality Assessment III (OPQA III), Division of Product Quality Assessment XIV (DPQA XIV)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: opeyemi.ajayi@fda.hhs.gov
Jackie L. Cullinan
2CDER, OPQ, Office of Pharmaceutical Quality Research (OPQR), Division of Pharmaceutical Quality Research VI (DPQR VI)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Innara Basria
2CDER, OPQ, Office of Pharmaceutical Quality Research (OPQR), Division of Pharmaceutical Quality Research VI (DPQR VI)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Madaisabel Fuentes-Arias
2CDER, OPQ, Office of Pharmaceutical Quality Research (OPQR), Division of Pharmaceutical Quality Research VI (DPQR VI)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashley Osuna-Najarro
2CDER, OPQ, Office of Pharmaceutical Quality Research (OPQR), Division of Pharmaceutical Quality Research VI (DPQR VI)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah Johnson
1Center for Drug Evaluation and Research (CDER), Office of Pharmaceutical Quality (OPQ), Office of Product Quality Assessment III (OPQA III), Division of Product Quality Assessment XIV (DPQA XIV)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Talia Faison
3CDER, OPQ, Office of Pharmaceutical Manufacturing Assessment (OPMA), Division of Pharmaceutical Manufacturing Assessment VI (DPMA VI)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Lute
2CDER, OPQ, Office of Pharmaceutical Quality Research (OPQR), Division of Pharmaceutical Quality Research VI (DPQR VI)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Scott.Lute@fda.hhs.gov
  • Article
  • References
  • Info & Metrics
  • PDF
Loading

Article Information

pdajpst.2025-000001
DOI 
https://doi.org/10.5731/pdajpst.2025-000001.1
PubMed 
40300813

Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Received January 6, 2025
  • Accepted March 17, 2025
  • Published online April 29, 2025.

Copyright & Usage 
Copyright © 2025, Parenteral Drug Association

Author Information

  1. Opeyemi O. Ajayi (opeyemi.ajayi{at}fda.hhs.gov)1,
  2. Jackie L. Cullinan2,
  3. Innara Basria2,
  4. Madaisabel Fuentes-Arias2,
  5. Ashley Osuna-Najarro2,
  6. Sarah Johnson1,
  7. Talia Faison3 and
  8. Scott Lute (Scott.Lute{at}fda.hhs.gov)2
  1. 1Center for Drug Evaluation and Research (CDER), Office of Pharmaceutical Quality (OPQ), Office of Product Quality Assessment III (OPQA III), Division of Product Quality Assessment XIV (DPQA XIV)
  2. 2CDER, OPQ, Office of Pharmaceutical Quality Research (OPQR), Division of Pharmaceutical Quality Research VI (DPQR VI)
  3. 3CDER, OPQ, Office of Pharmaceutical Manufacturing Assessment (OPMA), Division of Pharmaceutical Manufacturing Assessment VI (DPMA VI)
  1. Corresponding author: Scott Lute, CDER/OPQ/OPQR/DPQR VI, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD, 20993. Scott.Lute{at}fda.hhs.gov

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 79 (2)
PDA Journal of Pharmaceutical Science and Technology
Vol. 79, Issue 2
March/April 2025
  • Table of Contents
  • Index by Author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Analysis of virus clearance for biotechnology manufacturing processes from early to late phase development
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Analysis of virus clearance for biotechnology manufacturing processes from early to late phase development
Opeyemi O. Ajayi, Jackie L. Cullinan, Innara Basria, Madaisabel Fuentes-Arias, Ashley Osuna-Najarro, Sarah Johnson, Talia Faison, Scott Lute
PDA Journal of Pharmaceutical Science and Technology Apr 2025, pdajpst.2025-000001; DOI: 10.5731/pdajpst.2025-000001.1

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Analysis of virus clearance for biotechnology manufacturing processes from early to late phase development
Opeyemi O. Ajayi, Jackie L. Cullinan, Innara Basria, Madaisabel Fuentes-Arias, Ashley Osuna-Najarro, Sarah Johnson, Talia Faison, Scott Lute
PDA Journal of Pharmaceutical Science and Technology Apr 2025, pdajpst.2025-000001; DOI: 10.5731/pdajpst.2025-000001.1
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Settle plates with a diameter of 150 mm can be exposed to unidirectional airflow for up to 8 hours
  • A biosafety toolbox for manufacturing with single-use systems
  • Coring and fragmentation of elastomeric needle shield in a pre-filled syringe
Show more Research Paper

Similar Articles

Keywords

  • Viral Safety
  • Virus Clearance
  • Low pH inactivation
  • Virus-Retentive Filtration
  • Chromatography Viral Clearance
  • Pharmaceutical Viral Clearance
  • Retrovirus-Like Particle Clearance
  • Safety Factor

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire